ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients

J. Kwun, B. Ezekian, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Yi, S. Knechtle

Surgery, Duke Transplant Center, Durham, NC

Meeting: 2019 American Transplant Congress

Abstract number: 26

Keywords: Alloantibodies, B cells, Co-stimulation, T helper cells

Session Information

Date: Sunday, June 2, 2019

Session Name: Concurrent Session: Kidney Immunosuppression: Desensitization

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:30pm-2:42pm

Location: Ballroom A

Related Abstracts
  • Carfilzomib and Belatacept Reduces DSA and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation
  • Dual Targeting of Costimulation and Proteasome to Desensitize and Prolong Graft Survival of Sensitized Nonhuman Primates.

*Purpose: Broad human leukocyte antigen sensitization is a significant barrier to successful solid organ transplantation. Sensitized patients have poor access to donor organs, high wait list mortality, and when transplanted, inferior graft survival due to acute and chronic antibody-mediated injuries. We hypothesized that simultaneously targeting germinal center (GC) response with belatacept (Bela) and plasma cells (PC) with carfilzomib (CFZ) would produce durable desensitization without interfering protective humoral immunity in highly sensitized nonhuman primate kidney transplantation.

*Methods: Maximally MHC-mismatched rhesus pairs were sensitized with two sequential skin transplants and then desensitized with CFZ (27 mg/m2 IV) and Bela (20 mg/kg IV) weekly for one month. Blood, lymph node (LN), and bone marrow (BM) cells as well as serum were analyzed pre-, post-desensitization, and post-kidney transplantation.

*Results: CFZ/Bela (n=6) significantly reduced donor-specific antibody (DSA) (p = 0.0453). However, anti-tetanus and anti-CMV (gB) antibodies were not affected by the treatment. While circulating T and B cell counts were unchanged, CFZ/Bela significantly reduced BM-PC (CD19+CD38+, 7.3±2.1 vs. 5.4±2.2; p=0.019) and showed a strong trend of reduced LN-Tfh cells (CD4+ICOS+PD1hi , 9.9±7.2 vs. 6.9±4.6; p=0.06) (Fig 1). Unexpectedly, LN Treg cells also declined (CD4+CD25+CD127lo, 11.8±2.4 vs. 8.2±1.6; p=0.038). However, LN-Tfr cells were not significantly reduced (CD4+CXCR5+ICOS+PD1hi; p=0.13). Graft survival was significantly prolonged (p=0.016) and renal biopsy at one month showed significant reduction of AMR score (g+ptc+c4d; p=0.012) in CFZ/Bela treated animals compared to controls (n=4). Furthermore, all animals showed no CMV reactivation as was seen in parallel experiments using dual costimulation blockade with bortezomib. However, four out of five long-term animals showed gradual rebound of LN-PC and LN-Tfh cells while BM-PC did not fully recover by 100 days.

*Conclusions: We employed a mechanistically designed desensitization regimen using proteasome inhibitor and costimulation blockade in a rigorous, highly sensitized nonhuman primate model and demonstrate that this regimen reduces DSA, BM-PCs, and LN-Tfh cells without reducing anti-TT and anti-CMV Ab levels. Even though desensitization with CFZ/Bela markedly prolongs allograft survival, most animals eventually experienced AMR with rebound GC response, suggesting that desensitization needs to be maintained using ongoing suppression of the B cell response.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kwun J, Ezekian B, Schroder P, Manook M, Yoon J, Mulvihill M, Freischlag K, Yi J, Knechtle S. Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/costimulation-blockade-modulates-humoral-responses-in-highly-sensitized-transplant-recipients/. Accessed March 2, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.